These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Unexpected prolonged paralysis after mivacurium in a patient with Bamforth syndrome. Yildiz TS; Solak M; Baris I; Toker K Paediatr Anaesth; 2006 Aug; 16(8):892-4. PubMed ID: 16884476 [No Abstract] [Full Text] [Related]
27. Asystole associated with mivacurium. Else TA Anaesthesia; 1994 Oct; 49(10):926. PubMed ID: 7802217 [No Abstract] [Full Text] [Related]
28. [Mivacurium, fluid flow or human error]. Nouri M; Rouchet M; Bailly M Ann Fr Anesth Reanim; 1998; 17(9):1181-2. PubMed ID: 9835993 [No Abstract] [Full Text] [Related]
29. The importance of myorelaxants in anesthesia. Flood P Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920 [TBL] [Abstract][Full Text] [Related]
30. Priming rapacuronium: a comparison with rocuronium and mivacurium. Steinberg D Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782 [TBL] [Abstract][Full Text] [Related]
32. Effects of succinylcholine on the recovery of block produced by mivacurium in rats. Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002 [TBL] [Abstract][Full Text] [Related]
33. Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing. Rosenberg MK; Lebenbom-Mansour M Anesth Analg; 1997 Feb; 84(2):457-60. PubMed ID: 9024049 [No Abstract] [Full Text] [Related]
34. A comparison of intubation conditions and time-course of action with rocuronium and mivacurium for day case anaesthesia. Pendeville PE; Lois F; Scholtes JL Eur J Anaesthesiol; 2007 Jun; 24(6):546-50. PubMed ID: 17241507 [TBL] [Abstract][Full Text] [Related]
35. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy. Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs. Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070 [TBL] [Abstract][Full Text] [Related]
37. Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency. Niazi A; Leonard IE; O'Kelly B J Clin Anesth; 2004 Feb; 16(1):40-2. PubMed ID: 14984858 [TBL] [Abstract][Full Text] [Related]
38. Anesthesia management of a child with adrenoleukodystrophy. Hamdiye CT; Yavuz G; Kamil T; Mine S Paediatr Anaesth; 2006 Feb; 16(2):221-2. PubMed ID: 16430428 [No Abstract] [Full Text] [Related]
39. [Prolonged muscle weakness associated with the administration of non-depolarizing neuromuscular blocking agents in critically ill patients]. López MP; Seiz A; Criado A Rev Esp Anestesiol Reanim; 2001 Oct; 48(8):375-83. PubMed ID: 11674984 [TBL] [Abstract][Full Text] [Related]
40. The identification of mivacurium and metabolites in biological samples. Montgomery MA; LeBeau MA; Miller ML; Jufer RA J Anal Toxicol; 2005 Oct; 29(7):637-42. PubMed ID: 16419393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]